| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |